87 related articles for article (PubMed ID: 17227027)
1. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.
Whitworth GE; Macauley MS; Stubbs KA; Dennis RJ; Taylor EJ; Davies GJ; Greig IR; Vocadlo DJ
J Am Chem Soc; 2007 Jan; 129(3):635-44. PubMed ID: 17227027
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.
Rao FV; Dorfmueller HC; Villa F; Allwood M; Eggleston IM; van Aalten DM
EMBO J; 2006 Apr; 25(7):1569-78. PubMed ID: 16541109
[TBL] [Abstract][Full Text] [Related]
3. Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance.
Macauley MS; Bubb AK; Martinez-Fleites C; Davies GJ; Vocadlo DJ
J Biol Chem; 2008 Dec; 283(50):34687-95. PubMed ID: 18842583
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of a group A streptococcal glycoside hydrolase Spy1600 from family 84 reveals it is a beta-N-acetylglucosaminidase and not a hyaluronidase.
Sheldon WL; Macauley MS; Taylor EJ; Robinson CE; Charnock SJ; Davies GJ; Vocadlo DJ; Black GW
Biochem J; 2006 Oct; 399(2):241-7. PubMed ID: 16822234
[TBL] [Abstract][Full Text] [Related]
5. Diaminocyclopentane - l-Lysine Adducts: Potent and selective inhibitors of human O-GlcNAcase.
Weber P; Bojarová P; Brouzdová J; Křen V; Kulik N; Stütz AE; Thonhofer M; Wrodnigg TM
Bioorg Chem; 2024 Jul; 148():107452. PubMed ID: 38763001
[TBL] [Abstract][Full Text] [Related]
6. Structural snapshots of the reaction coordinate for O-GlcNAc transferase.
Lazarus MB; Jiang J; Gloster TM; Zandberg WF; Whitworth GE; Vocadlo DJ; Walker S
Nat Chem Biol; 2012 Dec; 8(12):966-8. PubMed ID: 23103939
[TBL] [Abstract][Full Text] [Related]
7. Highly functionalized diaminocyclopentanes: A new route to potent and selective inhibitors of human O-GlcNAcase.
Weber P; Mészáros Z; Bojarová P; Ebner M; Fischer R; Křen V; Kulik N; Müller P; Vlachová M; Slámová K; Stütz AE; Thonhofer M; Torvisco A; Wrodnigg TM; Wolfsgruber A
Bioorg Chem; 2023 Nov; 140():106819. PubMed ID: 37666109
[TBL] [Abstract][Full Text] [Related]
8. Structural studies of a surface-entropy reduction mutant of O-GlcNAcase.
Males A; Davies GJ
Acta Crystallogr D Struct Biol; 2019 Jan; 75(Pt 1):70-78. PubMed ID: 30644846
[TBL] [Abstract][Full Text] [Related]
9. Bypassing the proline/thiazoline requirement of the macrocyclase PatG.
Oueis E; Stevenson H; Jaspars M; Westwood NJ; Naismith JH
Chem Commun (Camb); 2017 Nov; 53(91):12274-12277. PubMed ID: 29090689
[TBL] [Abstract][Full Text] [Related]
10. Use of Fluorinated Functionality in Enzyme Inhibitor Development: Mechanistic and Analytical Advantages.
Berkowitz DB; Karukurichi KR; de la Salud-Bea R; Nelson DL; McCune CD
J Fluor Chem; 2008 Sep; 129(9):731-742. PubMed ID: 19727327
[TBL] [Abstract][Full Text] [Related]
11. O-GlcNAcylation: cellular physiology and therapeutic target for human diseases.
Ye L; Ding W; Xiao D; Jia Y; Zhao Z; Ao X; Wang J
MedComm (2020); 2023 Dec; 4(6):e456. PubMed ID: 38116061
[TBL] [Abstract][Full Text] [Related]
12. GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders.
Martínez-Bailén M; Clemente F; Matassini C; Cardona F
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890122
[TBL] [Abstract][Full Text] [Related]
13.
Zhang H; Qi J; Pei J; Zhang M; Shang Y; Li Z; Wang Y; Guo J; Sun K; Fan J; Sui L; Xu Y; Kong L; Kong Y
J Adv Res; 2022 Mar; 37():119-131. PubMed ID: 35499042
[TBL] [Abstract][Full Text] [Related]
14. KasQ an Epimerase Primes the Biosynthesis of Aminoglycoside Antibiotic Kasugamycin and KasF/H Acetyltransferases Inactivate Its Activity.
Rattinam R; Basha RS; Wang YL; Wang ZC; Hsu NS; Lin KH; Zadeh SM; Adhikari K; Lin JP; Li TL
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203422
[TBL] [Abstract][Full Text] [Related]
15. Advances in chemical probing of protein
Saha A; Bello D; Fernández-Tejada A
Chem Soc Rev; 2021 Sep; 50(18):10451-10485. PubMed ID: 34338261
[TBL] [Abstract][Full Text] [Related]
16. The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer's Disease.
Bukke VN; Villani R; Archana M; Wawrzyniak A; Balawender K; Orkisz S; Ferraro L; Serviddio G; Cassano T
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33086751
[TBL] [Abstract][Full Text] [Related]
17. 1,4-Dideoxy-1,4-imino-d-arabinitol (DAB) Analogues Possessing a Hydrazide Imide Moiety as Potent and Selective α-Mannosidase Inhibitors.
Haarr MB; Lopéz Ó; Pejov L; Fernández-Bolaños JG; Lindbäck E; Sydnes MO
ACS Omega; 2020 Jul; 5(29):18507-18514. PubMed ID: 32743229
[TBL] [Abstract][Full Text] [Related]
18. Molecular Interrogation to Crack the Case of O-GlcNAc.
Estevez A; Zhu D; Blankenship C; Jiang J
Chemistry; 2020 Sep; 26(53):12086-12100. PubMed ID: 32207184
[TBL] [Abstract][Full Text] [Related]
19. Computational Studies on the Potency and Selectivity of PUGNAc Derivatives Against GH3, GH20, and GH84 β-N-acetyl-D-hexosaminidases.
Dong L; Shen S; Xu Y; Wang L; Feng R; Zhang J; Lu H
Front Chem; 2019; 7():235. PubMed ID: 31111026
[TBL] [Abstract][Full Text] [Related]
20. The β-
Bojarová P; Kulik N; Hovorková M; Slámová K; Pelantová H; Křen V
Molecules; 2019 Feb; 24(3):. PubMed ID: 30743988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
